Gossamer Bio, Inc.
DE ˙ DB ˙ US38341P1021
0,17 € ↑0,02 (10,16%)
2026-06-05
DEL PRIS
SecurityDE:4GB / Gossamer Bio, Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership92,690 shares
Latest Disclosed Value $ 29,661
Jpmorgan Chase & Co reports 78.39% decrease in ownership of 4GB / Gossamer Bio, Inc.

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 92,690 shares of Gossamer Bio, Inc. (DE:4GB) valued at $25,471 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 428,903 shares of Gossamer Bio, Inc.. This represents a change in shares of -78.39% during the quarter. The current value of the position is $15,572 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 GOSSAMER BIO COMMON 38341P102 92,690 -336,213 -78.39 30 -97.82 0.0000
2026-05-13 2026-03-31 13F GOSSAMER BIO COMMON 38341P102 0 -100.00 0
2026-02-11 2025-12-31 13F GOSSAMER BIO COMMON 38341P102 428,903 234,534 120.66 1,330 160.08 0.0001
2025-11-26 2025-09-30 13F/A-1 GOSSAMER BIO COMMON 38341P102 194,369 103,922 114.90 511 360.36 0.0000
2025-11-07 2025-09-30 13F GOSSAMER BIO COMMON 38341P102 194,369 103,922 511 0.0000
2025-08-12 2025-06-30 13F GOSSAMER BIO COMMON 38341P102 90,447 74,825 478.97 111 552.94 0.0000
2025-05-12 2025-03-31 13F GOSSAMER BIO COMMON 38341P102 15,622 10,484 204.05 17 325.00 0.0000
2025-02-12 2024-12-31 13F GOSSAMER BIO COMMON 38341P102 5,138 4,444 640.35 5 0.0000
2024-12-26 2024-09-30 13F/A-1 GOSSAMER BIO COMMON 38341P102 694 0 0.00 1 0.0000
2024-11-08 2024-09-30 13F GOSSAMER BIO COMMON 38341P102 694 0 1 0.0000
2024-12-26 2024-06-30 13F/A-1 GOSSAMER BIO COMMON 38341P102 694 -201,204 -99.66 1 -100.00 0.0000
2024-08-12 2024-06-30 13F GOSSAMER BIO COMMON 38341P102 694 -201,204 1 0.0000
2024-12-26 2024-03-31 13F/A-1 GOSSAMER BIO COMMON 38341P102 201,898 201,898 238 0.0000
2024-05-10 2024-03-31 13F GOSSAMER BIO COMMON 38341P102 201,898 201,898 238 0.0000
2024-12-26 2023-12-31 13F/A-1 GOSSAMER BIO COMMON 38341P102 0 -43,583 -100.00 0 -100.00
2024-02-12 2023-12-31 13F GOSSAMER BIO COMMON 38341P102 0 -43,583 0
2023-11-14 2023-09-30 13F GOSSAMER BIO COMMON 38341P102 43,583 39,627 1,001.69 36 800.00 0.0000
2023-08-11 2023-06-30 13F GOSSAMER BIO COMMON 38341P102 3,956 -115,677 -96.69 5 -97.35 0.0000
2023-05-18 2023-03-31 13F/A-1 GOSSAMER BIO COMMON 38341P102 119,633 -797,936 -86.96 151 15,000.00 0.0000
2023-05-11 2023-03-31 13F GOSSAMER BIO COMMON 38341P102 33,692 -883,877 90 0.0000
2023-02-13 2022-12-31 13F GOSSAMER BIO COMMON 38341P102 917,569 844,868 1,162.11 2 -99.89 0.0003
2022-11-14 2022-09-30 13F GOSSAMER BIO COMMON 38341P102 72,701 13,697 23.21 871 75.96 0.0001
2022-08-11 2022-06-30 13F GOSSAMER BIO COMMON 38341P102 59,004 -51,309 -46.51 495 -48.28 0.0001
2022-05-11 2022-03-31 13F GOSSAMER BIO COMMON 38341P102 110,313 64,083 138.62 957 82.98 0.0001
2022-02-11 2021-12-31 13F/A-1 GOSSAMER BIO COMMON 38341P102 46,230 3,685 8.66 523 -2.24 0.0001
2022-02-10 2021-12-31 13F GOSSAMER BIO COMMON 38341P102 46,230 3,685 523 0.0001
2021-11-12 2021-09-30 13F GOSSAMER BIO COMMON 38341P102 42,545 1,932 4.76 535 62.12 0.0001
2021-08-12 2021-06-30 13F GOSSAMER BIO COMMON 38341P102 40,613 6,666 19.64 330 4.76 0.0000
2021-05-12 2021-03-31 13F GOSSAMER BIO COMMON 38341P102 33,947 6,465 23.52 315 18.42 0.0000
2021-02-19 2020-12-31 13F/A-1 GOSSAMER BIO COMMON 38341P102 27,482 4,360 18.86 266 -10.44 0.0000
2021-02-11 2020-12-31 13F GOSSAMER BIO COMMON 38341P102 27,482 4,360 266 6.5784
2020-11-12 2020-09-30 13F/A-1 GOSSAMER BIO COMMON 38341P102 23,122 6,368 38.01 297 36.24 0.0000
2020-11-12 2020-09-30 13F GOSSAMER BIO COMMON 38341P102 23,122 297
2020-08-11 2020-06-30 13F GOSSAMER BIO COMMON 38341P102 16,754 2,615 18.49 218 51.39 0.0000
2020-05-12 2020-03-31 13F GOSSAMER BIO COMMON 38341P102 14,139 213 1.53 144 -33.94 0.0000
2020-02-11 2019-12-31 13F GOSSAMER BIO COMMON 38341P102 13,926 -133 -0.95 218 -7.63 0.0000
2019-11-12 2019-09-30 13F GOSSAMER BIO COMMON 38341P102 14,059 8,064 134.51 236 87.30 0.0000
2019-08-07 2019-06-30 13F GOSSAMER BIO COMMON 38341P102 5,995 2,798 87.52 126 82.61 0.0000
2019-05-07 2019-03-31 13F GOSSAMER BIO COMMON 38341P102 3,197 3,197 69 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.